{"name": "immatics biotechnologies",
 "permalink": "immatics-biotechnologies",
 "crunchbase_url": "http://www.crunchbase.com/company/immatics-biotechnologies",
 "homepage_url": "http://www.immatics.net",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@immatics.com",
 "phone_number": "49-7071-5397-100",
 "description": "",
 "created_at": "Thu Mar 11 07:02:56 UTC 2010",
 "updated_at": "Tue Sep 21 14:36:49 UTC 2010",
 "overview": "\u003Cp\u003Eimmatics is an independent biopharmaceutical company that focuses on the development of new immunotherapeutic substances for cancer therapy. The product can50 didates from immatics are based upon tumor-associated peptides (TUMAPs) that specifically stimulate the immune system against cancer cells. In September 2006 \u00e2\u20ac\u201c and thus less than three years after the conclusion of the first round of funding totaling \u00e2\u201a\u00ac14 million \u00e2\u20ac\u201c the company\nsuccessfully concluded an international clinical study on its product candidate IMA901 for combating renal cancer. Further product candidates, also consisting of peptide-based immuno55 therapeutic substances for cancer therapy, are presently undergoing preclinical development and will serve as the basis for a rapidly expanding product pipeline.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[127,
       62],
      "assets/images/resized/0007/9914/79914v1-max-150x150.jpg"],
     [[127,
       62],
      "assets/images/resized/0007/9914/79914v1-max-250x250.jpg"],
     [[127,
       62],
      "assets/images/resized/0007/9914/79914v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u20ac102M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.tornado-insider.com/press/presses.asp?pressid=9011",
    "source_description": "immatics receives \u00e2\u201a\u00ac40 million in second round of funding",
    "raised_amount": 40000000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2007,
    "funded_month": 2,
    "funded_day": 8,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Wellington Partners",
         "permalink": "wellington-partners",
         "image":
          {"available_sizes":
            [[[150,
               26],
              "assets/images/resized/0001/9753/19753v1-max-150x150.png"],
             [[237,
               42],
              "assets/images/resized/0001/9753/19753v1-max-250x250.png"],
             [[237,
               42],
              "assets/images/resized/0001/9753/19753v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "3i Group",
         "permalink": "3i-group",
         "image":
          {"available_sizes":
            [[[70,
               68],
              "assets/images/resized/0001/9740/19740v1-max-150x150.png"],
             [[70,
               68],
              "assets/images/resized/0001/9740/19740v1-max-250x250.png"],
             [[70,
               68],
              "assets/images/resized/0001/9740/19740v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "DH Capital",
         "permalink": "dh-capital",
         "image":
          {"available_sizes":
            [[[110,
               134],
              "assets/images/resized/0006/1890/61890v2-max-150x150.png"],
             [[110,
               134],
              "assets/images/resized/0006/1890/61890v2-max-250x250.png"],
             [[110,
               134],
              "assets/images/resized/0006/1890/61890v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "OH Beteiligungen",
         "permalink": "oh-beteiligungen",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "NTEC",
         "permalink": "ntec",
         "image":
          {"available_sizes":
            [[[86,
               86],
              "assets/images/resized/0025/6628/256628v1-max-150x150.png"],
             [[86,
               86],
              "assets/images/resized/0025/6628/256628v1-max-250x250.png"],
             [[86,
               86],
              "assets/images/resized/0025/6628/256628v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "KfW Bankengruppe",
         "permalink": "kfw",
         "image":
          {"available_sizes":
            [[[123,
               65],
              "assets/images/resized/0005/2455/52455v2-max-150x150.png"],
             [[123,
               65],
              "assets/images/resized/0005/2455/52455v2-max-250x250.png"],
             [[123,
               65],
              "assets/images/resized/0005/2455/52455v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": 7500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2005,
    "funded_month": 4,
    "funded_day": 15,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Merifin Capital",
         "permalink": "merifin-capital",
         "image":
          {"available_sizes":
            [[[150,
               26],
              "assets/images/resized/0005/0293/50293v1-max-150x150.png"],
             [[250,
               43],
              "assets/images/resized/0005/0293/50293v1-max-250x250.png"],
             [[285,
               50],
              "assets/images/resized/0005/0293/50293v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "EMBL Ventures",
         "permalink": "embl-ventures",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0006/8288/68288v1-max-150x150.jpg"],
             [[191,
               67],
              "assets/images/resized/0006/8288/68288v1-max-250x250.jpg"],
             [[191,
               67],
              "assets/images/resized/0006/8288/68288v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Grazia Equity",
         "permalink": "grazia-equity",
         "image":
          {"available_sizes":
            [[[150,
               78],
              "assets/images/resized/0002/9088/29088v2-max-150x150.jpg"],
             [[230,
               120],
              "assets/images/resized/0002/9088/29088v2-max-250x250.jpg"],
             [[230,
               120],
              "assets/images/resized/0002/9088/29088v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "3i Deutschland Gesellschaft f\u00fcr Industriebeteiligungen",
         "permalink": "3i-deutschland-gesellschaft-fr-industriebeteiligungen",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Wellington Partners",
         "permalink": "wellington-partners",
         "image":
          {"available_sizes":
            [[[150,
               26],
              "assets/images/resized/0001/9753/19753v1-max-150x150.png"],
             [[237,
               42],
              "assets/images/resized/0001/9753/19753v1-max-250x250.png"],
             [[237,
               42],
              "assets/images/resized/0001/9753/19753v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "VINCI CAPITAL",
         "permalink": "vinci-capital",
         "image":
          {"available_sizes":
            [[[150,
               30],
              "assets/images/resized/0005/3918/53918v1-max-150x150.jpg"],
             [[250,
               50],
              "assets/images/resized/0005/3918/53918v1-max-250x250.jpg"],
             [[284,
               57],
              "assets/images/resized/0005/3918/53918v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "L-Bank",
         "permalink": "l-bank",
         "image":
          {"available_sizes":
            [[[150,
               55],
              "assets/images/resized/0008/9150/89150v1-max-150x150.jpg"],
             [[182,
               67],
              "assets/images/resized/0008/9150/89150v1-max-250x250.jpg"],
             [[182,
               67],
              "assets/images/resized/0008/9150/89150v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "c",
    "source_url": "http://www.immatics.com/index.php?page=18\u0026modaction=detail\u0026modid=249\u0026modid2=2010",
    "source_description": "immatics raises \u00e2\u201a\u00ac54 million to advance its late stage clinical therapeutic cancer vaccine portfolio",
    "raised_amount": 54000000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2010,
    "funded_month": 9,
    "funded_day": 21,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "dievini Hopp Biotech Holding",
         "permalink": "dievini-hopp-biotech-holding",
         "image":
          {"available_sizes":
            [[[150,
               44],
              "assets/images/resized/0010/1829/101829v1-max-150x150.jpg"],
             [[250,
               73],
              "assets/images/resized/0010/1829/101829v1-max-250x250.jpg"],
             [[284,
               84],
              "assets/images/resized/0010/1829/101829v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Wellington Partners",
         "permalink": "wellington-partners",
         "image":
          {"available_sizes":
            [[[150,
               26],
              "assets/images/resized/0001/9753/19753v1-max-150x150.png"],
             [[237,
               42],
              "assets/images/resized/0001/9753/19753v1-max-250x250.png"],
             [[237,
               42],
              "assets/images/resized/0001/9753/19753v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MIG-advised funds",
         "permalink": "mig-advised-funds",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "AT Impf",
         "permalink": "at-impf",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Paul-Ehrlich-Str. 15",
    "address2": "",
    "zip_code": "72076",
    "city": "Tuebingen",
    "state_code": null,
    "country_code": "DEU",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        99],
       "assets/images/resized/0007/9915/79915v1-max-150x150.jpg"],
      [[250,
        165],
       "assets/images/resized/0007/9915/79915v1-max-250x250.jpg"],
      [[450,
        298],
       "assets/images/resized/0007/9915/79915v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}